Kadmon Holdings Inc KDMN

Kadmon Holdings Inc

Biotechnology

Healthcare

KDMN

172M shares

NASDAQ US

traded

08 Nov 2021

open

9.49

52 week high

9.50

high

9.50

52 week low

3.19

low

9.48

growth

123%

previous Close

9.48

P/E ratio

-48

market cap

1.70B

div yield

0

usd

Sep 2021

qoq

revenue

14.71K

-92.54 %

net incoming

-33.04K

99.89 %

eps

-0.20

-11.11 %

eps surprise

-2.35 %

net profit margin

-224.69 %

15178.00 %

operating incoming

-26.39K

99.92 %

net change in cash

-63.19M

9.90 %

cash on hand

68.83M

11.22 %

cost of revenue

643

-94.15 %